Inhibition of neutrophil function by KSHV vOX2 protein

SAR Rezaee; JA Gracie; IB McInnes; David Blackbourn

Inhibition of neutrophil function by KSHV vOX2 protein

SAR Rezaee, JA Gracie, IB McInnes, David Blackbourn

Cancer and Genomic Sciences

Research output: Contribution to journal › Article

33 Citations (Scopus)

Abstract

Kaposi's sarcoma is multifactorial, involving Kaposi's sarcoma-associated herpesvirus (KSHV) infection and immune dysfunction. A KSHV protein (vOX2), fused with the Fc domain of human immunoglobulin G1 to create vOX2:Fc, suppressed neutrophil oxidative burst and inhibited the production of pro-inflammatory chemokines (IL-8 and monocyte chemoattractant protein 1) by monocyte/macrophage cells. vOX2:Fc suppressed the acute inflammatory response in mice in which neutrophil-mediated inflammation was induced by carrageenan. The data suggest that vOX2 can contribute to immune dysfunction and could have anti-inflammatory therapeutic potential.

Original language	English
Pages (from-to)	1907-1910
Number of pages	4
Journal	Aids
Volume	19
Publication status	Published - 1 Jan 2005

Cite this

@article{16f53faabc3d433cb83c8df32fbc085c,

title = "Inhibition of neutrophil function by KSHV vOX2 protein",

abstract = "Kaposi's sarcoma is multifactorial, involving Kaposi's sarcoma-associated herpesvirus (KSHV) infection and immune dysfunction. A KSHV protein (vOX2), fused with the Fc domain of human immunoglobulin G1 to create vOX2:Fc, suppressed neutrophil oxidative burst and inhibited the production of pro-inflammatory chemokines (IL-8 and monocyte chemoattractant protein 1) by monocyte/macrophage cells. vOX2:Fc suppressed the acute inflammatory response in mice in which neutrophil-mediated inflammation was induced by carrageenan. The data suggest that vOX2 can contribute to immune dysfunction and could have anti-inflammatory therapeutic potential.",

author = "SAR Rezaee and JA Gracie and IB McInnes and David Blackbourn",

year = "2005",

month = jan,

day = "1",

language = "English",

volume = "19",

pages = "1907--1910",

journal = "Aids",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Inhibition of neutrophil function by KSHV vOX2 protein

AU - Rezaee, SAR

AU - Gracie, JA

AU - McInnes, IB

AU - Blackbourn, David

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Kaposi's sarcoma is multifactorial, involving Kaposi's sarcoma-associated herpesvirus (KSHV) infection and immune dysfunction. A KSHV protein (vOX2), fused with the Fc domain of human immunoglobulin G1 to create vOX2:Fc, suppressed neutrophil oxidative burst and inhibited the production of pro-inflammatory chemokines (IL-8 and monocyte chemoattractant protein 1) by monocyte/macrophage cells. vOX2:Fc suppressed the acute inflammatory response in mice in which neutrophil-mediated inflammation was induced by carrageenan. The data suggest that vOX2 can contribute to immune dysfunction and could have anti-inflammatory therapeutic potential.

AB - Kaposi's sarcoma is multifactorial, involving Kaposi's sarcoma-associated herpesvirus (KSHV) infection and immune dysfunction. A KSHV protein (vOX2), fused with the Fc domain of human immunoglobulin G1 to create vOX2:Fc, suppressed neutrophil oxidative burst and inhibited the production of pro-inflammatory chemokines (IL-8 and monocyte chemoattractant protein 1) by monocyte/macrophage cells. vOX2:Fc suppressed the acute inflammatory response in mice in which neutrophil-mediated inflammation was induced by carrageenan. The data suggest that vOX2 can contribute to immune dysfunction and could have anti-inflammatory therapeutic potential.

M3 - Article

C2 - 16227799

VL - 19

SP - 1907

EP - 1910

JO - Aids

JF - Aids

ER -

Inhibition of neutrophil function by KSHV vOX2 protein

Abstract

Fingerprint

Cite this